| Net Cash Provided by (Used in) Operating Activities |
143M |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
103M |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-321M |
USD |
-415% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
111M |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Shares, Issued |
15.2M |
shares |
+0.29% |
Q4 2024 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-73M |
USD |
-4.29% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.48B |
USD |
+94.9% |
Q1 2025 |
Q1 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
32M |
USD |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
124M |
USD |
-20.5% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
543M |
USD |
-7.5% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
596M |
USD |
-36.9% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
242M |
USD |
+18.6% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
45M |
shares |
0% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
599M |
USD |
+2.39% |
Q1 2025 |
Q1 2025 |
| Depreciation, Depletion and Amortization |
3M |
USD |
-82.4% |
Q1 2023 |
Q1 2023 |
| Deferred Tax Assets, Net of Valuation Allowance |
419M |
USD |
-2.78% |
Q4 2024 |
FY 2024 |
| Interest Expense |
90M |
USD |
+1.12% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |